428 related articles for article (PubMed ID: 31594934)
1. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer.
Zhang Z; Lee JH; Ruan H; Ye Y; Krakowiak J; Hu Q; Xiang Y; Gong J; Zhou B; Wang L; Lin C; Diao L; Mills GB; Li W; Han L
Nat Commun; 2019 Oct; 10(1):4562. PubMed ID: 31594934
[TBL] [Abstract][Full Text] [Related]
2. Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer.
Wang R; Tang Q
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073237
[TBL] [Abstract][Full Text] [Related]
3. HeRA: an atlas of enhancer RNAs across human tissues.
Zhang Z; Hong W; Ruan H; Jing Y; Li S; Liu Y; Wang J; Li W; Diao L; Han L
Nucleic Acids Res; 2021 Jan; 49(D1):D932-D938. PubMed ID: 33119754
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
[No Abstract] [Full Text] [Related]
5. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential.
Lee JH; Xiong F; Li W
RNA Biol; 2020 Nov; 17(11):1550-1559. PubMed ID: 31916476
[TBL] [Abstract][Full Text] [Related]
6. Genetic, Pharmacogenomic, and Immune Landscapes of Enhancer RNAs Across Human Cancers.
Zhang Z; Luo M; Li Q; Liu Y; Lussier C; Zhang J; Ye Y; Guo AY; Han L
Cancer Res; 2022 Mar; 82(5):785-790. PubMed ID: 35022213
[TBL] [Abstract][Full Text] [Related]
7. Enhancer-derived RNA: A Primer.
Liu F
Genomics Proteomics Bioinformatics; 2017 Jun; 15(3):196-200. PubMed ID: 28533025
[TBL] [Abstract][Full Text] [Related]
8. Functional annotation of structural ncRNAs within enhancer RNAs in the human genome: implications for human disease.
Ren C; Liu F; Ouyang Z; An G; Zhao C; Shuai J; Cai S; Bo X; Shu W
Sci Rep; 2017 Nov; 7(1):15518. PubMed ID: 29138457
[TBL] [Abstract][Full Text] [Related]
9. Insights into Enhancer RNAs: Biogenesis and Emerging Role in Brain Diseases.
Shen Y; Huang Z; Yang R; Chen Y; Wang Q; Gao L
Neuroscientist; 2023 Apr; 29(2):166-176. PubMed ID: 34612730
[TBL] [Abstract][Full Text] [Related]
10. Enhancer RNA (eRNA) in Human Diseases.
Wang Y; Zhang C; Wang Y; Liu X; Zhang Z
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232885
[TBL] [Abstract][Full Text] [Related]
11. Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.
Rahman S; Zorca CE; Traboulsi T; Noutahi E; Krause MR; Mader S; Zenklusen D
Nucleic Acids Res; 2017 Apr; 45(6):3017-3030. PubMed ID: 27932455
[TBL] [Abstract][Full Text] [Related]
12. A prospective study revealing the role of an immune-related eRNA, WAKMAR2, in breast cancer.
Wang L; Liu J; Tai J; Zhou N; Huang T; Xue Y; Quan Z
Sci Rep; 2021 Jul; 11(1):15328. PubMed ID: 34321580
[TBL] [Abstract][Full Text] [Related]
13. Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression.
Fang K; Huang W; Sun YM; Chen TQ; Zeng ZC; Yang QQ; Pan Q; Han C; Sun LY; Luo XQ; Wang WT; Chen YQ
Genome Biol; 2020 Nov; 21(1):269. PubMed ID: 33143730
[TBL] [Abstract][Full Text] [Related]
14. Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls.
Hauberg ME; Fullard JF; Zhu L; Cohain AT; Giambartolomei C; Misir R; Reach S; Johnson JS; Wang M; Mattheisen M; Børglum AD; Zhang B; Sieberts SK; Peters MA; Domenici E; Schadt EE; Devlin B; Sklar P; Roeder K; Roussos P;
Mol Psychiatry; 2019 Nov; 24(11):1685-1695. PubMed ID: 29740122
[TBL] [Abstract][Full Text] [Related]
15. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation.
Li W; Notani D; Ma Q; Tanasa B; Nunez E; Chen AY; Merkurjev D; Zhang J; Ohgi K; Song X; Oh S; Kim HS; Glass CK; Rosenfeld MG
Nature; 2013 Jun; 498(7455):516-20. PubMed ID: 23728302
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional Landscape of Enhancer RNAs in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus.
Guo G; Wang H; Tong X; Ye L; Shi X; Fang S; Hu Y; Han F; Chen C; Ding N; Su B; Xue X; Zhang H
J Inflamm Res; 2022; 15():775-791. PubMed ID: 35153501
[TBL] [Abstract][Full Text] [Related]
17. The dynamic landscape of enhancer-derived RNA during mouse early embryo development.
Yu H; Zhao J; Shen Y; Qiao L; Liu Y; Xie G; Chang S; Ge T; Li N; Chen M; Li H; Zhang J; Wang X
Cell Rep; 2024 Apr; 43(4):114077. PubMed ID: 38592974
[TBL] [Abstract][Full Text] [Related]
18. eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer.
Zhang X; Pang P; Jiang M; Cao Q; Li H; Xu Y; Li Y; Chen X; Han J
Dis Markers; 2020; 2020():8847986. PubMed ID: 33029258
[TBL] [Abstract][Full Text] [Related]
19. Enhancer RNAs and regulated transcriptional programs.
Lam MT; Li W; Rosenfeld MG; Glass CK
Trends Biochem Sci; 2014 Apr; 39(4):170-82. PubMed ID: 24674738
[TBL] [Abstract][Full Text] [Related]
20. Spirits in the Material World: Enhancer RNAs in Transcriptional Regulation.
Hou TY; Kraus WL
Trends Biochem Sci; 2021 Feb; 46(2):138-153. PubMed ID: 32888773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
